title: Protections for clinical trials in low and middle income countries need strengthening not weakening.
authors.affiliation: Clinical Research, BUC (Biosciences UAM+CSIC) Program, International Campus of Excellence, Universidad Autónoma de Madrid, E-28049 Madrid, Spain Rafael.dalre@fuam.uam.es.
authors.forename: Rafael
authors.initials: R
authors.lastname: Dal-Ré
authors.affiliation: Medical Research Council of Zimbabwe, Causeway, Harare, Zimbabwe.
authors.forename: Paul
authors.initials: P
authors.lastname: Ndebele
authors.affiliation: Division of Clinical Research, Office of the Director, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Higgs
authors.affiliation: College of Health Sciences, Makerere University, Makerere, Uganda.
authors.forename: Nelson
authors.initials: N
authors.lastname: Sewankambo
authors.affiliation: Unit on Vulnerable Populations, Department of Bioethics, NIH Clinical Center, Bethesda, Maryland, USA.
authors.forename: David
authors.initials: D
authors.lastname: Wendler
mesh_terms: D002986:Clinical Trials as Topic / Q000941:ethics*; D003906:Developing Countries; D006801:Humans; D007182:Income / Q000706:statistics & numerical data; D010344:Patient Advocacy / Q000941:ethics* / Q000592:standards*